THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
D000792:Angiography; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D005853:Geriatrics; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013924:Thrombophlebitis; D013925:Thromboplastin; D013927:Thrombosis; D014568:Urokinase-Type Plasminogen Activator
D005343:Fibrinolytic Agents; D013925:Thromboplastin; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
ANGIOGRAPHY; DRUG THERAPY; FIBRINOLYSIS; GERIATRICS; INFUSIONS, PARENTERAL; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS; THROMBOPLASTIN; THROMBOSIS